A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice

A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice

Safinamide is an approved drug for the treatment of motor fluctuations in Parkinson’s disease (PD). Scarce data are available on its use in clinical practice. A group of Spanish movement disorders specialists was convened to review the use of safinamide across different clinical scenarios...

Full description

Bibliographic Details
Main Authors: Javier Pagonabarraga, José Matías Arbelo, Francisco Grandas, Maria-Rosario Luquin, Pablo Martínez Martín, Mari Cruz Rodríguez-Oroz, Francesc Valldeoriola, Jaime Kulisevsky
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Brain Sciences
Subjects:
safinamide
efficacy
safety
fluctuations
dyskinesia
rand/ucla appropriateness method
Online Access:https://www.mdpi.com/2076-3425/10/3/176

Internet

https://www.mdpi.com/2076-3425/10/3/176

Similar Items